(Date:11/21/2009)...Eric J. Hall, president and chief executive office...ssued the following statement regarding the inclus...he new annual wellness for Medicare beneficiaries ...e Act" that was introduced last night: , ... 21, 2009 -- Eric J. Hall, president and chief exe...
(Date:11/20/2009)... Nov. 20 /PRNewswire-FirstCall/ - NUCRYST Pharmace...ng of Shareholders will be held on Monday, Decembe...der approval of two special resolutions. The first...e sale of all or substantially all of the assets o... in the asset purchase agreement dated November 10...
(Date:11/20/2009)...Senators and Congressmen in Competitive Re-electio...re Vote , Washington, DC ...men running for re-election next year in races dee...ok, may come to regret voting for House Speaker Na...a breaking Zogby International/ O’Leary Repo...
(Date:11/20/2009)...srael, November 20 Cardi.../www.CVSLMEDICAL.COM , a leading,developer of adva...unced that,the company,s Board of Directors has de...anada and the Far East for its proprietary next-ge...angioplasty (PCTA) procedures. , Cardio V...
(Date:11/20/2009)...nline November 20 in the Journal of the National ...and hopes that often appear in news coverage of ca... both the media and journals to help alleviate the...even Woloshin, M.D., M.S., of Center for Medicine ...h Policy and Clinical Practice in New Hampshire, a...
Breaking Medicine News(10 mins):Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2...are twice as likely to develop rheumatoid arthriti... suggests research published ahead of print in the... support the fetal origin of disease theory, which...h blood pressure, for example, have been linked to...
...use to regulate emotions can determine both neurol...wards, a team of New York University and Rutgers U...ings, reported in the most recent issue of the jou...trategies can alter responses to negative events. ...
...at Wake Forest University Baptist Medical Center a...r a new cancer treatment will be as effective at e... in mice. , The treatment will involve transfusi...lood cells from cancer-resistant mice has previous...
...08 OptiNose announced today that it presented imp...ance of its novel nasal drug delivery device with ...hase II results indicate that the drug-device comb...tiNose presented the data at the Annual Scientific...
...wing demand for novel polymer and process developm...ment as an invaluable resource to medical device c...C (PRWEB) June 27, 2008 -- Zeus, Inc. introduced i... York. Showcasing its expertise, confidentiality,...
...N.J., June 27 /PRNewswire-FirstCall/,-- Schering-P...YSE: MRK ),announce the withdrawal of the New Dru... combination tablet., The companies also terminat... that would combine loratadine and,montelukast. Th...
Other Medicine News:Health News:NYU, Rutgers study shows how using mental strategies can alter the brain's reward circuitry 2Health News:Cancer 'cure' in mice to be tested in humans 2Health News:Cancer 'cure' in mice to be tested in humans 3Health News:OptiNose presents data on highly effective migraine treatment 2Health News:Contract Research Development Debuts at MD&M Touting Expertise, Innovation and Collaboration 2(Date:11/19/2009)..., Nov. 19 In a series of...nce, Heska Corporation (Nasdaq: HSKA ) ("Heska" o... new and improved website. The upgraded site is t...d programming to align the site with the company,s...(Logo: http://www.newscom.com/cgi-bin/prnh/20000...
(Date:11/19/2009)...lif., Nov. 19 Alexza Pha...y that its corporate presentation will be webcast ...are Conference on Wednesday, December 2, 2009 at 9...ebcast from The New York Palace Hotel in New York ...esident and CEO. ,, To access the live presen...
(Date:11/19/2009)...., Nov. 19 The D e al...of its Most Admired Corporate Dealmakers for the s... as its Most Admired Dealmaker in pharma/biotech f...s and divestitures since January 2006. ,, Over ...portfolio with a focus on high-growth, innovation-...
Breaking Medicine Technology:Heska Announces Launch of New Website 2Heska Announces Launch of New Website 3Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3The Deal Names Abbott Top Dealmaker for Second Consecutive Year 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 3Appeals Court Rules in Favor of Prometheus Upholds the Patentability of Its Claims for Methods of Thiopurine Metabolite Testing 57519 1Appeals Court Rules in Favor of Prometheus Upholds the Patentability of Its Claims for Methods of Thiopurine Metabolite Testing 57519 2Anthem Blue Cross and Blue Shield Foundation Grant Supporting American Diabetes Associations Family Link Program In Connecticut 57514 1Anthem Blue Cross and Blue Shield Foundation Grant Supporting American Diabetes Associations Family Link Program In Connecticut 57514 2Anthem Blue Cross and Blue Shield Foundation Grant Supporting American Diabetes Associations Family Link Program In Connecticut 57514 3Leading American Healthcare Experts Press Congress to Act Quickly on Health Reform 57511 1Leading American Healthcare Experts Press Congress to Act Quickly on Health Reform 57511 2Leading American Healthcare Experts Press Congress to Act Quickly on Health Reform 57511 3Leading American Healthcare Experts Press Congress to Act Quickly on Health Reform 57511 4...confirms safety and HbA1c reductions seen in ische...ier clinical trials -, ORLANDO, Fla., Nov. 6 CV ...y that data from a prospectively identified,analys...-36 study showed,that Ranexa(R) (ranolazine extend...in A1c (HbA1c), increased the number of patients a...
...nd Clinic Researchers Highlight the Need For More ...al Trials, ORLANDO, Fla., Nov. 6 Cleveland Clini...n a significant minority in,cardiovascular randomi...,Lung and Blood Institute (NHLBI). Lead Author, E...enon,M.D., and a team of Cleveland Clinic research...
Other Medicine Technology:CV Therapeutics' Anti-Ischemic Agent Ranexa(R) Significantly Reduces HbA1c and Other Markers of Diabetes in MERLIN TIMI-36 2CV Therapeutics' Anti-Ischemic Agent Ranexa(R) Significantly Reduces HbA1c and Other Markers of Diabetes in MERLIN TIMI-36 3CV Therapeutics' Anti-Ischemic Agent Ranexa(R) Significantly Reduces HbA1c and Other Markers of Diabetes in MERLIN TIMI-36 4Enrollment of Women in Cardiovascular Trials Fails to Meet Current Federal Mandates 2...el is a viscous antimicrobial that contains 10% Po...pectrum germicidal action. As a preoperative patie... pooling of prepping solutions under the patient, ...e Iodine Topical Gel is film forming, creating a d...
Povidone Iodine Prep Solution (PVP-I Prep Flip-Top Cap)
Idophor PVP Scrub Winged Sponges
Triad Plus Povidone Iodine (PVP-I) Scrub Winged Sponges
Medicine Products: